Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZILUCOPLAN vs ZIPRASIDONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ZILUCOPLAN vs ZIPRASIDONE: Safety Overview

Metric ZILUCOPLAN ZIPRASIDONE
Total FAERS Reports 441 3,551
Deaths Reported 23 515
Death Rate 5.2% 14.5%
Hospitalizations 163 1,164
Average Patient Age 58.8 yrs 37.6 yrs
% Female Patients 53.6% 55.8%
FDA Approval Date Oct 17, 2023 Aug 22, 2017
Manufacturer UCB, Inc. Apotex Corp.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription